Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30258790 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TDP1ADRA2BPTGS1CYP3A4 | |
| Hydrochloric Acid SCHEMBL312522 | 0.98 | ALDH1A1 (0.60) | ALDH1A1TDP1ADRA2BPTGS1CYP3A4 | |
| SCHEMBL23888255 | 0.85 | ALDH1A1 (0.56) | ALDH1A1TDP1ADRA2BPTGS1CYP3A4 | |
| SCHEMBL30178244 | 0.85 | ALDH1A1 (0.56) | ALDH1A1TDP1ADRA2BPTGS1CYP3A4 | |
| SCHEMBL8174091 | 0.83 | CYP3A4 (0.62) | ALDH1A1TDP1ADRA2BPTGS1CYP3A4 | |
| SCHEMBL146841 | 0.82 | CA1 (0.61) | ALDH1A1TDP1ADRA2BPTGS1CYP3A4 | |
| SCHEMBL18550731 | 0.81 | ALDH1A1 (0.57) | ALDH1A1TDP1ADRA2BPTGS1CYP3A4 | |
| SCHEMBL5159608 | 0.81 | TDP1 (0.57) | ALDH1A1TDP1ADRA2BPTGS1TSHR | |
| SCHEMBL13394018 | 0.81 | CYP3A4 (0.59) | ALDH1A1TDP1ADRA2BPTGS1CYP3A4 | |
| SCHEMBL6289998 | 0.79 | CYP3A4 (0.56) | ALDH1A1TDP1ADRA2BPTGS1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 692 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9249091-B2 | Post-treated sulfurized salt of an alkyl-substituted hydroxyaromatic composition | CHEVRON ORONITE COMPANY LLC (US) | 2016-02-02 | — | — | US | claimed |
| US-20130165359-A1 | POST-TREATED SULFURIZED SALT OF AN ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOSITION | CHEVRON ORONITE COMPANY LLC (US) | 2013-06-27 | — | — | US | claimed |
| US-8288552-B2 | Dihydropyridone amidesas P2X7 modulators | ROCHE PALO ALTO LLC (US) | 2012-10-16 | — | — | US | claimed |
| US-7056986-B2 | ethylene monomer can be a vinyl ketone, ether, ester, halide, nitrile, aromatic, or an allyl ether; acrylic monomer can be a mono- or diacid or monoester of a diacid; a monoamine, a guanidine compound, and an aromatic diamine; improved vulcanizability, balance between processability and compression set | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 2006-06-06 | — | — | US | claimed |
| CN-122055368-A | PKMYT1 inhibiting compounds and uses thereof | 杭州中美华东制药有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4126879-B1 | N-PHENYL SUBSTITUTED INDOLE DERIVATIVES AS MYT1 INHIBITORS FOR THE TREATMENT OF CANCER | REPARE THERAPEUTICS INC (CA) | 2026-01-21 | — | — | EP | disclosed |
| US-20250346593-A1 | IMIDAZO(1,2-1)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS | INTERLINE THERAPEUTICS INC (US) | 2025-11-13 | — | — | US | disclosed |
| US-12433826-B2 | Primer and kit of primer and dental material | KETTENBACH GMBH & CO. KG (DE) | 2025-10-07 | — | — | US | disclosed |
| US-12435090-B2 | Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use | REPARE THERAPEUTICS INC. (CA) | 2025-10-07 | — | — | US | disclosed |
| WO-2025077716-A1 | PKMYT1 INHIBITORY COMPOUND AND USE THEREOF | 杭州中美华东制药有限公司 | 2025-04-17 | — | — | WO | disclosed |
| CN-119698416-A | Imidazo (1, 2-A) pyridine derivatives as RIPK2 inhibitors | 英特莱治疗公司 | 2025-03-25 | — | — | CN | disclosed |
| EP-4524139-A1 | IMIDAZOPYRIDAZINE SUBSTITUTED BENZENE RING DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | Shanghai Simr Biotechnology Co., Ltd. (CN) | 2025-03-19 | — | — | EP | disclosed |
| US-4762644-A | AROMATIC POLYAMINE WITH ANIONICDOPES | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1988-08-09 | — | — | US | disclosed |
| EP-0214310-A1 | CONDUCTIVE POLYMER SOLUTION AND PROCESS FOR PRODUCING CONDUCTIVE ARTICLES FROM THE SOLUTION | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1987-03-18 | — | — | EP | disclosed |
| EP-0038458-B1 | 4-HYDROXY-1,2-BENZISOTHIAZOL-3(2H)-ONE-1,1-DIOXIDE, THEIR SALTS, THEIR PREPARATION AND THEIR UTILIZATION | Dr. Karl Thomae GmbH (DE) | 1983-09-21 | — | — | EP | disclosed |
| US-4404230-A | ARTICIFIAL SWEETENERS | DR. KARL THOMAE GMBH (DE) | 1983-09-13 | — | — | US | disclosed |
| EP-0038458-A1 | 4-Hydroxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide, their salts, their preparation and their utilization | Dr. Karl Thomae GmbH (DE) | 1981-10-28 | — | — | EP | disclosed |
| US-4058642-A | HYPERTENSIVE | BOEHRINGER INGELHEIM GMBH (DT) | 1977-11-15 | — | — | US | disclosed |
| US-3997548-A | INSECTICIDE | GULF RESEARCH & DEVELOPMENT COMPANY (US) | 1976-12-14 | — | — | US | disclosed |
| US-3954997-A | MITICIDES, INSECTICIDES | THE UPJOHN COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12433826-B2 | Primer and kit of primer and dental material | MVD, KIT, POLL | ALDH1A1 337/4885TDP1 1732/4885ADRA2B 4284/4885 |
| US-20250346593-A1 | IMIDAZO(1,2-1)PYRIDINE DERIVATIVES AS RIPK2 INHIBITORS | RIPK2, RIPK1, RIPK4 | ALDH1A1 3792/4885TDP1 938/4885ADRA2B 4228/4885 |
| US-20130165359-A1 | POST-TREATED SULFURIZED SALT OF AN ALKYL-SUBSTITUTED HYDROXYAROMATIC COMPOSITION | TST, PAH, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | ALDH1A1 814/4885TDP1 1379/4885ADRA2B 541/4885 |
| US-12435090-B2 | Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use | PLK1, CSNK1A1, CSNK1G1 | ALDH1A1 4093/4885TDP1 677/4885ADRA2B 3145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.